ExaShape in Practice: Which Configuration, Which Patient, and How to Use It
Why ExaShape, in which cases, which configuration, and how it is used in theatre, from the flap decision to the refinement stage.
Read article →
The Cost-Effectiveness of Breast Reconstruction: What Actually Drives the Numbers
Unit price is the least informative number in reconstruction economics. Complications, theatre time and the number of operations drive cost; the unit…
Read article →
Biologic or Synthetic Mesh in Breast Reconstruction: The Evidence and the Trade-Offs
The randomised head-to-heads favour synthetic mesh on seroma; biological matrices offer integration into thin cover. The choice is made patient by patient.
Read article →
How to Compare Mesh Studies in Breast Reconstruction (and Why 9% and 38% Can Both Be Right)
Headline complication rates for the same material range from under 10% to nearly 40%. Seven questions explain why, and show how to…
Read article →
Meshes and Matrices in Breast Reconstruction: What They Do and What the Evidence Says
"Mesh" is a family, not a product. Subpectorally the question is whether to use one; prepectorally it is which one, configured how.
Read article →
Prepectoral or Subpectoral: What the Evidence Now Shows
Pooled data favour prepectoral placement on three outcomes and disfavour it on none. The evidence is consistent but observational, and the first…
Read article →
Direct-to-Implant or Two-Stage: Reading a Meta-Analysis, a Trial and a Cohort Together
A meta-analysis, a randomised trial and a prospective cohort give three different answers. Selection on the mastectomy flap explains all three.
Read article →
Implant-Based or Autologous Reconstruction: What the Comparative Evidence Shows
The best comparative study measured both trades at once: autologous tissue scores higher on satisfaction, implants carry fewer complications. The choice is…
Read article →
What the CE Mark Tells You, and the Six Questions It Does Not Answer
The CE mark answers whether a device meets the regulation for its intended purpose. It does not answer whether it is the…
Read article →
When Mastectomy Is Chosen: What the Evidence Says, and What Reconstruction Owes the Patient
Fifty years of trials say conservation is at least as safe as mastectomy for eligible women. When mastectomy is the plan, the…
Read article →